Anti-IL-20 [7E]
AB03713-23.0
ApplicationsELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetIL20
Overview
- SupplierAbsolute Antibody
- Product NameAnti-IL-20 [7E]
- Delivery Days Customer9
- Antibody SpecificityThis antibody binds human Interleukin-20 (IL-20). IL-20 is a pro-inflammatory and angiogenic cytokine mainly secreted by monocytes, granulocytes, dendritic cells and skin keratinocytes that plays crucial roles in immune responses, regulation of inflammato
- Application Supplier NoteThe binding characterization of this antibody towards human IL-20 was done using ELISA. This antibody inhibits IL-20 induced proliferation of calf pulmonary artery endothelial cells (CPAEs) and human HUVEC cells in vitro (US7786274). The therapeutic efficacy of this antibody was also tested in a collagen-induced arthritis (CIA) rat model. In vivo, treatment with 7E alone or in combination with etanercept significantly reduced the severity of arthritis by decreasing the hind paw thickness and swelling, preventing cartilage damage and bone loss, and reducing the expression of IL-20, IL-1beta, IL-6, RANKL, and matrix metalloproteinases (MMPs) in synovial tissue. Selectively blocking IL-20 inhibited inflammation and bone loss in rats with CIA (PMID: 20722035).
- ApplicationsELISA, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID7E
- Gene ID50604
- Target nameIL20
- Target descriptioninterleukin 20
- Target synonymscytokine Zcyto10; four alpha helix cytokine; IL10D; IL-20; interleukin-20; ZCYTO10
- HostRabbit
- IsotypeIgG
- Protein IDQ9NYY1
- Protein NameInterleukin-20
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203